Target intelligence / Profile preview

Fatty acid beta-oxidation pathway (medium-chain specificity)

Molecular classification
Enzyme pathway, Metabolic process, Other
01

Overview

The **fatty acid beta‐oxidation pathway** is a central mitochondrial process by which **fatty acids are broken down to generate energy**, primarily in the form of ATP. Medium‐chain fatty acids (MCFAs), such as octanoic and decanoic acids, are rapidly oxidized via this route. The process involves several key steps: 1. **Activation:** MCFAs are activated to their CoA derivatives by specific acyl-CoA synthetases. 2. **Transport:** Unlike long‐chain fatty acids that require carnitine shuttling into mitochondria, MCFAs can enter mitochondria more readily. 3. **Beta-Oxidation Cycle:** Inside mitochondria, a series of enzymatic reactions sequentially shortens the acyl chain by two carbons per cycle, producing acetyl-CoA for entry into the citric acid cycle and generating NADH/FADH₂ for oxidative phosphorylation[1][3]. 4. In humans and other mammals, these steps involve enzymes such as *medium-chain acyl-CoA dehydrogenase* (MCAD), enoyl-CoA hydratase, hydroxyacyl-CoA dehydrogenase, and ketoacyl-CoA thiolase[1][2]. This rapid oxidation is particularly important during fasting or ketogenic diets when glucose is scarce; it supports ketone body production for brain energy supply[4]. Defects in any step—especially MCAD deficiency—can lead to serious metabolic disorders. **Note on Target Validity:** "Energy metabolism via rapid oxidation of medium-chain fatty acids" describes a biological *process*, not a single molecular target like an enzyme or receptor. Therefore, - It is not considered a canonical therapeutic target. - The entry should be flagged as incorrect if strict molecular targeting information is required. References supporting these statements include detailed reviews on mitochondrial beta‐oxidation pathways and their role in health/disease[1][2][3][4].

Other names
Medium-chain fatty acid oxidationMCFA beta-oxidationMitochondrial fatty acid oxidation (medium-chain)Beta-oxidation of medium-chain fatty acids
02

Biological functions

Energy metabolismKetone body productionATP generation
03

Disease associations

Inborn errors of metabolism (e.g., medium-chain acyl-CoA dehydrogenase deficiency)Neurological disorders (via energy supply/ketogenesis)Other metabolic diseases

Beyond the preview

Go deeper on Fatty acid beta-oxidation pathway (medium-chain specificity).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fatty acid beta-oxidation pathway (medium-chain specificity).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call